Maha Katabi, Director at Vera Therapeutics, Inc. (VERA), sold 1,274,244 shares at $44.00 ($52.1M) on 2024-03-21, disclosed to the SEC on 2024-03-25.
Open-market sale of $52.1M VERA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.00 | 32,756 | $1.4M | 2.7% |
| 2 | $44.00 | 21,918 | $964K | 1.9% |
| 3 | $45.52 | 12,617 | $574K | 1.1% |
| 4 | $45.52 | 12,617 | $574K | 1.1% |
| 5 | $46.18 | 13,718 | $633K | 1.2% |
| 6 | $46.18 | 13,718 |
| $633K |
| 1.2% |
| 7 | $40.51 | 413,450 | $16.7M | 32.2% |
| 8 | $40.51 | 413,450 | $16.7M | 32.2% |
| 9 | $40.50 | 340,000 | $13.8M | 26.5% |
| Total | $40.85 avg | 1,274,244 | $52.1M | 100% |
| Filing → |
| VERA | BUY | 2022-02-14 | $4.0M | — | Filing → |
| AVTE | BUY | 2021-07-06 | $5.0M | — | Filing → |
| VERA | BUY | 2021-05-18 | $8.0M | — | Filing → |